Vihinen M, Villa A, Mella P, Schumacher R F, Savoldi G, O'Shea J J, Candotti F, Notarangelo L D
Institute of Medical Technology, University of Tampere, FIN-33014, Finland.
Clin Immunol. 2000 Aug;96(2):108-18. doi: 10.1006/clim.2000.4880.
Hereditary severe combined immunodeficiency (SCID) includes a heterogeneous group of diseases that profoundly affect both cellular and humoral immune responses and require treatment by bone marrow transplantation. Characterization of the cellular and molecular bases of SCID is essential to provide accurate genetic counseling and prenatal diagnosis, and it may offer the grounds for alternative forms of treatment. The Jak3 gene is mutated in most cases of autosomal recessive T(-)B(+) SCID in humans. Jak3 belongs to the family of intracellular Janus tyrosine kinases. It is physically and functionally coupled to the common gamma chain, gammac, shared by several cytokine receptors. We have established the JAK3base registry for disease and mutation information. In order to study the structural consequences of the Jak3 mutations, the structure of the human Jak3 kinase and pseudokinase domains was modeled. Residues involved in ATP and Mg(2+) binding were highly conserved in the kinase domain whereas the substrate binding region is somewhat different compared to other kinases. We have identified the first naturally occurring mutations disrupting the function of the human Jak3 kinase domain. The structural basis of all of the known Jak3 mutations reported so far is discussed based on the modeled structure. The model of the Jak3 protein also permits us to study Jak3 phosphorylation at the structural level and may thus serve in the design of novel immune suppressive drugs.
遗传性重症联合免疫缺陷(SCID)包括一组异质性疾病,这些疾病会严重影响细胞免疫和体液免疫反应,需要通过骨髓移植进行治疗。对SCID的细胞和分子基础进行表征对于提供准确的遗传咨询和产前诊断至关重要,并且可能为替代治疗形式提供依据。在大多数人类常染色体隐性T(-)B(+)SCID病例中,Jak3基因发生突变。Jak3属于细胞内Janus酪氨酸激酶家族。它在物理和功能上与几种细胞因子受体共有的共同γ链γc偶联。我们已经建立了JAK3base疾病和突变信息登记库。为了研究Jak3突变的结构后果,对人Jak3激酶和假激酶结构域的结构进行了建模。参与ATP和Mg(2+)结合的残基在激酶结构域中高度保守,而底物结合区域与其他激酶相比有所不同。我们已经鉴定出第一个破坏人Jak3激酶结构域功能的天然突变。基于建模结构讨论了迄今为止报道的所有已知Jak3突变的结构基础。Jak3蛋白模型还使我们能够在结构水平上研究Jak3磷酸化,因此可用于设计新型免疫抑制药物。